MARATTO

article · Dermatology Practical & Conceptual

Propranolol: A Promising Therapeutic Avenue for Classic Kaposi Sarcoma

20251 citationOpen accessAlexandria University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Oral propranolol is a safe and good option for treatment of patients with non-complicated classic KS, especially elderly with multiple comorbidities.

Research topics

  • Vascular Malformations and Hemangiomas
  • Viral-associated cancers and disorders
  • Ear and Head Tumors

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5826/dpc.1501a4737

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.